HMGB1 and major depressive disorder: Given prior evidence linking elevated HMGB1 to depression and stress-related neuroimmune dysregulation, it was hypothesized that ECT might exert therapeutic effects by downregulating HMGB1-mediated inflammatory pathways or modulating sRAGE expression.